Combination therapy for advanced breast cancer: Cyclophosphamide, doxorubicin, UFT, and tamoxifen

ONCOLOGY

Volumn 13, Issue 7 SUPPL., 1999, Pages 77-81

  Fukuda, Mamoru ^a   Yamaguchi, Susumu ^a   Ohta, Tomohiko ^a   Nakayama, Yoshiaki ^a   Ogata, Haruki ^a   Shimizu, Kaname ^a   Nishikawa, Toru ^a   Adachi, Yukihiro ^b   Fukuma, Eisuke ^c  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Toyoko Hospital   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; TAMOXIFEN; TAMOXIFEN CITRATE; UFT;

ADVANCED CANCER; ALOPECIA; ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RECURRENCE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFICACY; DRUG SAFETY; HUMAN; LEUKOPENIA; MALAISE; ORAL DRUG ADMINISTRATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; DOXORUBICIN; DRUG ADMINISTRATION ROUTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TAMOXIFEN; TEGAFUR; TREATMENT OUTCOME; URACIL;

EID: 0032787575     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Hansen R, Quebbeman E, Beatty P, et al: Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat 10:145-149, 1987.
2. Hirata K, Sasaki K, Yamamitsu S, et al: A comparison of 5-fluorouracil concentration of 5- fluorouracil drip infusion versus oral UFT in plasma of same patients. Can To Kagaku Ryoho 20:1409-1411, 1993.
3. Namatame K, Sasaki E, Ko Y, et al: A double-blind comparison of FUra plasma concentration by oral (UFT) vs continuous intravenous infusion (5-FU). Gan To Kagaku Ryoho 20:2417-2419, 1993.
4. 1-(2′-tetrahydrofuryl)-5-fluorouracil. Clin Cancer Res 4(9):2085-2088, 1998.
5. Ota K, Taguchi T, Kimura K: Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol 22:333-338, 1988.
6. Tashiro H, Nomura Y, Osaki A: A double- blind comparative study of tegafur (FT) and UFT (a combination of tegafur and uracil) in advanced breast cancer. Jpn J Clin Oncol 24:212-216, 1994.